PTE News and Press, PolarityTE Inc. From 02/11/20

PolarityTE, Inc. (Nasdaq: PTE) , a biotechnology company developing and commercializing regenerative tissue products and biomaterials, today announced that it has commenced an underwritten public offering of shares of its common stock and warrants to purchase shares of its common stock. ...

Introduction to the Positive/Negative Forensic Value Stock Selections This quantitative study continues a series of multi-year test now using the top four forensic algorithms applied to detect bankruptcy risk, earnings manipulation, and financial irregularities. This forward testing study co...

This is not an article about investing in PTE. I have plenty of those, here is the latest . This is merely an update on recent events for anyone following the stock. So, That Happened Data by YCharts I woke up Thursday morning, as always, at 4 AM Pacific Time, and I saw all my acco...

Gainers: Neon Therapeutics (NASDAQ: NTGN )  +44% . More news on: Neon Therapeutics, Inc., NantKwest, Inc., Signet Jewelers Limited, Stocks on the move, , Read more ...

In late January 2019, as I gathered information for my monthly Stem Cell News and Analysis newsletter , I came across an obscure (at least in the U.S.) Australian-based company in the regenerative medicine space that I had never heard of before. Unknown to me, this company had accomplished ...

PolarityTE, Inc. (Nasdaq: PTE) , a biotechnology company developing and commercializing regenerative tissue products and biomaterials, announced today that senior management will host institutional investor and partnering meetings at the LifeSci Advisors Corporate Access Event taking place a...

Significant milestone reached in 2019 with additional patent applications approved in three countries PolarityTE, Inc. (Nasdaq: PTE) , a biotechnology company developing and commercializing regenerative tissue products and biomaterials, announced today that the company has recently be...

PolarityTE, Inc. (Nasdaq: PTE) , a biotechnology company developing and commercializing regenerative tissue products and biomaterials, today announced that it has entered into a $25.0 million equity purchase agreement (the “Agreement”) with Keystone Capital Partners, LLC (&#x...

Well, not quite as big as an aircraft carrier. US Navy New Captains At The Helm PolarityTE ( PTE ) is a commercial-stage biotech in the regenerative medicine field that has had a short and tumultuous existence and has been under new management since early June. I will go over some of i...

PolarityTE, Inc. (Nasdaq: PTE) , a biotechnology company developing and commercializing regenerative tissue products and biomaterials, today announced that it will attend the Evercore ISI HealthCONx Conference on Tuesday, December 3, 2019 in Boston and the Piper Jaffray 31 st Annual Healt...